Trial Profile
Bileacid Malabsorption and GLP-1 Secretion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Primary bile acid malabsorption
- Focus Pharmacodynamics
- 04 Aug 2017 Status changed from recruiting to completed.
- 28 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Aug 2017.
- 28 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 May 2017.